Bionaut Labs

Precision-targeted Medicine Modality for CNS Disorders

Health Tech & Life Sciences
Active
Series B Herzliya, Israel Founded 2016
Last updated 2026-06-18
Total raised
$69.2M
Last: B Round 2024-02
Stage
Series B
Founded
2016
Headcount
42
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

Bionaut Labs is a biotechnology start-up focused on treating central nervous system disorders (CNS) with its Bionaut precision medicine treatment modality. Bionaut uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted CNS disease areas. Through precision localized brain targeting, Bionaut therapeutics could offer better efficacy and safety that cannot be achieved by other traditional treatment modalities.

Two of the company's earliest indications are for gliomas and Huntington's disease. The Bionaut therapeutic-containing drug targets a disease similarly to how a traditional modality targets a disease. Bionauts are custom-engineered therapeutic micro-robots that target payloads to specific locations in the body. Bionauts can be constructed in different versions with custom geometries and surface characteristics. Smaller than a millimeter, they contain moving parts controlled remotely by a compact magnetic controller, allowing them to move.

Funding history · 3 rounds · $69.2M total

Q&A

What is Bionaut Labs' primary focus?
Bionaut Labs is a biotechnology startup focused on treating central nervous system (CNS) disorders using its Bionaut precision medicine treatment modality, which involves remote-controlled microscale robots to deliver therapies locally.
When was Bionaut Labs founded?
Bionaut Labs was founded in January 2016.
What is the total amount of funding Bionaut Labs has raised to date?
Bionaut Labs has raised a total of $69.2 million USD.
When did Bionaut Labs complete its most recent funding round?
Bionaut Labs completed a B Round in February 2024, raising $6 million USD.
Which investors participated in Bionaut Labs' February 2024 B Round?
OurCrowd, Upfront Ventures, Mayo Clinic Platform, and Khosla Ventures participated in Bionaut Labs' February 2024 B Round.
Which investors led Bionaut Labs' November 2022 B Round?
Khosla Ventures led Bionaut Labs' November 2022 B Round.
How many employees does Bionaut Labs currently have?
Bionaut Labs has 11-50 employees.
Who are the co-founders of Bionaut Labs?
The co-founders of Bionaut Labs are Aviad Maizels, Michael Shpigelmacher, and Alexander Shpunt.

Team · 5

Founder · Co-founder & Executive Chairman
LinkedIn ↗
Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

diagnosticsbiotechnologyrare-diseasesdrug-deliverybrain-disorderprecision-medicineparkinsontherapeuticsneurologyminimally-invasivecns-disorderstargeted-therapyroboticssurgery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)